Surgery Partners Inc. (NASDAQ:SGRY)’s share price traded up 2.7% on Thursday . The company traded as high as $18.13 and last traded at $18.07, with a volume of 63,922 shares traded. The stock had previously closed at $17.59.

A number of equities analysts have weighed in on the company. KeyCorp assumed coverage on Surgery Partners in a research report on Thursday, June 9th. They set an “overweight” rating and a $21.00 price target on the stock. Zacks Investment Research raised Surgery Partners from a “sell” rating to a “hold” rating in a research report on Thursday, April 14th. Citigroup Inc. decreased their target price on Surgery Partners from $25.00 to $21.00 and set a “buy” rating on the stock in a research report on Monday, March 14th. Royal Bank Of Canada decreased their target price on Surgery Partners from $22.00 to $20.00 and set an “outperform” rating on the stock in a research report on Monday, March 14th. Finally, Morgan Stanley reaffirmed a “hold” rating on shares of Surgery Partners in a research report on Friday, May 6th. Three equities research analysts have rated the stock with a hold rating, six have given a buy rating and one has given a strong buy rating to the company. Surgery Partners has an average rating of “Buy” and a consensus price target of $22.75.

The company has a market cap of $867.61 million and a price-to-earnings ratio of 715.60. The stock has a 50 day moving average price of $15.53 and a 200 day moving average price of $15.56.

Surgery Partners (NASDAQ:SGRY) last announced its quarterly earnings results on Thursday, May 5th. The company reported ($0.15) earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of $0.03 by $0.18. The company had revenue of $267.10 million for the quarter, compared to analyst estimates of $255.06 million. The company’s revenue was up 19.2% on a year-over-year basis. On average, analysts forecast that Surgery Partners Inc. will post $0.54 EPS for the current fiscal year.

Several institutional investors have recently bought and sold shares of the company. Sei Investments Co. purchased a new position in Surgery Partners during the fourth quarter valued at approximately $3,201,000. Oxford Asset Management purchased a new position in Surgery Partners during the fourth quarter valued at approximately $3,178,000. Wells Fargo & Company MN purchased a new position in Surgery Partners during the fourth quarter valued at approximately $14,025,000. Finally, Jennison Associates LLC purchased a new position in Surgery Partners during the fourth quarter valued at approximately $34,117,000.

Surgery Partners, Inc is a healthcare services company. The Company operates in three lines of business across the United States: Surgical Facility Services, Ancillary Services and Optical Services. The Company’s Surgical Facility Services segment consists of the operation of ambulatory surgery centers (ASCs) and surgical hospitals, which include its anesthesia services.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.